Abstract:Cancer-associated fibroblasts (CAFs) in the tumor microenvironment are involved in cancer development and progression, including breast cancer (BC). Up-regulation of CCL17 was observed in BC and predicted a decrease in overall survival, suggesting an important role of CCL17 in BC development. Nonetheless, little is known about the role of CCL17 in the interaction between CAFs and BC.Real-time quantitative PCR, Western blot, and enzyme-linked immunosorbent assay were performed to examine C-C motif chemokine ligand 17 (CCL17) and C-C motif chemokine receptor 4 (CCR4) levels in BC tissues and CAFs. Cell proliferation, migration, and invasion of CAFs co-cultured with or without BC cell lines were measured by Cell Counting Kit-8 and Transwell analysis. Expression of CCL17, CCR4, dual specificity phosphatase 6 (DUSP6), matrix metallopeptidase 13 (MMP13), extracellular signal-regulated kinase (ERK) 1/2, and phosphor-ERK1/2 (p-ERK1/2) in BC cell lines co-cultured with or without CAFs was measured by Western blotting.We found that BC tissues and CAFs demonstrated higher levels of CCL17 compared with adjacent-normal breast tissues and adjacent-normal fibroblasts (NFs), respectively. CCL17 expression is correlated with lymph nodes, TNM stage and tumor size of BC patients. CCL17 knockdown significantly inhibited CCL17 release, CCR4 expression, and the cell proliferation of CAFs, while CCL17 overexpression demonstrated an inverse effect in NFs. Co-culture with CAFs induced the increases in cell proliferation, migration, invasion, and the expression of CCL17, CCR4, MMP13, and p-ERK1/2 in MCF-7 and MDA-MB-231 cells were markedly reversed by CCL17 knockdown in CAFs. Meanwhile, co-culture with NFs induced the malignant phenotype of MCF-7 cells was markedly enhanced by CCL17 overexpression in NFs. Moreover, DUSP6, a negative regulator of ERK1/2, was dose-dependent decrease in response to recombinant CCL17 and inhibited cell migration, invasion, MMP13 expression, and ERK1/2 activation in MCF-7 cells.The findings of this study suggest that CCL17 may function as a novel biomarker as well as potential therapeutic target against BC and CAF-secreted CCL17 promotes BC cell migration and invasion through the DUSP6-dependent ERK1/2 pathway.

CXCL1 Stimulates Migration and Invasion in ER‑negative Breast Cancer Cells Via Activation of the ERK/MMP2/9 Signaling Axis

CXCL16/CXCR6 chemokine signaling mediates breast cancer progression by pERK1/2-dependent mechanisms.

Overexpression of ERα Inhibits Proliferation and Invasion of MKN28 Gastric Cancer Cells by Suppressing Β-Catenin

Cxcl5/Cxcr2 Axis Promotes Bladder Cancer Cell Migration And Invasion By Activating Pi3k/Akt-Induced Upregulation Of Mmp2/Mmp9

&Lt;p>down-Regulation of CCL17 in Cancer-Associated Fibroblasts Inhibits Cell Migration and Invasion of Breast Cancer Through ERK1/2 Pathway</p>

CCL18 Enhances Migration, Invasion and EMT by Binding CCR8 in Bladder Cancer Cells

Neurokinin-1 Receptor Mediated Breast Cancer Cell Migration by Increased Expression of MMP-2 and MMP-14.

Estrogen Promotes the Metastasis of Non‑small Cell Lung Cancer Via Estrogen Receptor Β by Upregulation of Toll‑like Receptor 4 and Activation of the Myd88/nf‑κb/mmp2 Pathway.

CXCR4 promotes oral squamous cell carcinoma migration and invasion through inducing expression of MMP-9 and MMP-13 via the ERK signaling pathway.

CXCL9 Is a Potential Biomarker of Immune Infiltration Associated With Favorable Prognosis in ER-Negative Breast Cancer

The Clinical Implications and Molecular Mechanism of CX3CL1 Expression in Urothelial Bladder Cancer

CCL17-CCR4 Axis Promotes Metastasis Via ERK/MMP13 Pathway in Bladder Cancer

Recruited Mast Cells in the Tumor Microenvironment Enhance Bladder Cancer Metastasis Via Modulation of ERβ/CCL2/CCR2 EMT/MMP9 Signals

Angiogenesis , Metastasis , and the Cellular Microenvironment CXCR 4 Promotes Oral Squamous Cell Carcinoma Migration and Invasion through Inducing Expression of MMP-9 and MMP-13 via the ERK Signaling Pathway

STAT3-induced NCK1 elevation promotes migration of triple-negative breast cancer cells via regulating ERK1/2 signaling

Identification of Potential Therapeutic Targets among CXC Chemokines in Breast Tumor Microenvironment Using Integrative Bioinformatics Analysis

Fibroblast ERα Promotes Bladder Cancer Invasion Via Increasing the CCL1 and IL-6 Signals in the Tumor Microenvironment.

CXCL2/MIF-CXCR2 Signaling Promotes the Recruitment of Myeloid-Derived Suppressor Cells and is Correlated with Prognosis in Bladder Cancer

ERα Inhibits Epithelial-Mesenchymal Transition by Suppressing Bmi1 in Breast Cancer.

Estrogen Stimulated Migration and Invasion of Estrogen Receptor-Negative Breast Cancer Cells Involves an Ezrin-Dependent Crosstalk Between G Protein-Coupled Receptor 30 and Estrogen Receptor Beta Signaling.

CCL21/CCR7 Interaction Promotes Cellular Migration and Invasion Via Modulation of the MEK/ERK1/2 Signaling Pathway and Correlates with Lymphatic Metastatic Spread and Poor Prognosis in Urinary Bladder Cancer.